TOP STORIES
We’re at SXSW. Many others are at SXSW. Read us first. But, in the meantime, here’s what some other people are saying.
- The cool kids at SXSW aren’t into biotech. Here’s why. – Forbes
- Big Pharma’s big bet on electroceuticals. – IEEE Spectrum
- During SXSW, virtual reality wants to prove it’s here to stay. – Voice of America
- Why the Tricorder XPrize is behind schedule. – IEEE Spectrum
- Cocoon Cam checks your baby’s heart rate and temperature without a wearable. – Wearable
LIFE SCIENCES
Here’s a preview of Valeant’s “watershed” moment on Tuesday, when it reports fourth-quarter earnings. – Financial Times
Unfortunately, this didn’t make me feel any better about the do-it-yourself CRISPR community. – STAT
Proskauer Rose is building up its IP practice to cater to the life sciences. – Boston Business Journal
India’s ban on codeine-based cough syrups have had an immediate impact on the Pfizer and Abbott business units. – Reuters
PAYERS-PROVIDERS
One of many great points in this piece discussing retail clinics and increases in healthcare spending: “Something that boosts convenience at a slight cost is considered bad in health care whereas it would be considered great in every other sector of the economy.” – The Health Care Blog
Here’s the back story on Harken Health, a UnitedHealth company trying an alternative approach to insurance: it offers unlimited access to primary care, without copays, if they visit a health center owned by Harken. – Star Tribune
TECHNOLOGY
An interesting back story on the issue of cybersecurity: the challenges for cyber insurance. – Xconomy
POLITICS
The topic of healthcare ebbs and flows in the national presidential debates and town halls. Here’s a look at how the candidates and their supporters are talking medicine in campaign speeches. – Forbes
A LITTLE BIT EXTRA
A compilation of Donald Trump’s thoughts on the tech industry, including: “Twitter will soon be irrelevant if lowlifes are so easily able to hack into accounts.” – VentureBeat
Photo: Getty Images
